Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Nucleotide anti-viral analogues, including adefovir and TDF, have demonstrated kidney
toxicity in HIV/HBV co-infected patients and HBV mono-infected European patients.
Investigators suspected similar kidney proximal tubular injury can also occur in HBV mono
infected Asian patients receiving TDF treatment.